Date: 2012-03-26 11:48:40

Biotechnology

Recombinant DNA

Kommanditgesellschaft auf Aktien

Pharmaceutical industry

Technology

Merck

Ventria Bioscience

Merck KGaA

Dear Ventria Shareholders: Today, Ventria and Merck KGaA announced an exclusive collaboration. Ventria will supply a recombinant protein made using the ExpressTec system to the EMD Millipore Division of Merck KGaA based

Document is deleted from original location.
Use the Download Button below to download from the Web Archive.

File Size: 130,90 KB